EP0546126A4 - Method and compositions for diagnosing and treating chronic fatigue immunodysfunction syndrome - Google Patents

Method and compositions for diagnosing and treating chronic fatigue immunodysfunction syndrome

Info

Publication number
EP0546126A4
EP0546126A4 EP19920904738 EP92904738A EP0546126A4 EP 0546126 A4 EP0546126 A4 EP 0546126A4 EP 19920904738 EP19920904738 EP 19920904738 EP 92904738 A EP92904738 A EP 92904738A EP 0546126 A4 EP0546126 A4 EP 0546126A4
Authority
EP
European Patent Office
Prior art keywords
diagnosing
compositions
chronic fatigue
treating chronic
syndrome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19920904738
Other versions
EP0546126A1 (en
Inventor
Elaine Defreitas
Brendan Hilliard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wistar Institute of Anatomy and Biology
Original Assignee
Wistar Institute of Anatomy and Biology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wistar Institute of Anatomy and Biology filed Critical Wistar Institute of Anatomy and Biology
Publication of EP0546126A1 publication Critical patent/EP0546126A1/en
Publication of EP0546126A4 publication Critical patent/EP0546126A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
EP19920904738 1990-08-29 1991-08-29 Method and compositions for diagnosing and treating chronic fatigue immunodysfunction syndrome Withdrawn EP0546126A4 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US57469090A 1990-08-29 1990-08-29
US574690 1990-08-29
US68659491A 1991-04-17 1991-04-17
US686594 1991-04-17
US70216191A 1991-05-16 1991-05-16
US702161 1991-05-16

Publications (2)

Publication Number Publication Date
EP0546126A1 EP0546126A1 (en) 1993-06-16
EP0546126A4 true EP0546126A4 (en) 1993-07-21

Family

ID=27416186

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19920904738 Withdrawn EP0546126A4 (en) 1990-08-29 1991-08-29 Method and compositions for diagnosing and treating chronic fatigue immunodysfunction syndrome

Country Status (7)

Country Link
EP (1) EP0546126A4 (en)
JP (1) JPH06500928A (en)
AU (1) AU657516B2 (en)
CA (1) CA2089761A1 (en)
IE (1) IE913042A1 (en)
PT (1) PT98812A (en)
WO (1) WO1992005760A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2109603A1 (en) * 1991-05-23 1992-11-26 William J. Martin Stealth virus detection in the chronic fatigue syndrome
JPH10503364A (en) * 1994-05-10 1998-03-31 ザ ジェネラル ホスピタル コーポレーション Antisense inhibition of hepatitis C virus
GB9518154D0 (en) * 1995-09-06 1995-11-08 Lynxvale Ltd Oligonucleotides and their use
DE102011005878A1 (en) 2010-03-22 2011-12-01 Wilfried P. Bieger Determining neuromodulatory or mental disorders using arrangements for liquid chromatography, comprises measuring concentrations of neurotransmitters in blood cells and carrying out concentration measurements in thrombocytes
DE202010004193U1 (en) 2010-03-22 2011-05-05 Bieger, Wilfried P., Priv.-Doz. Dr.med.habil. Test kits for the determination of neuroregulatory and mental disorders
RU2458666C1 (en) * 2011-02-11 2012-08-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Северо-Западный государственный медицинский университет имени И.И. Мечникова" Министерства здравоохранения и социального развития Российской Федерации Method of treating patients with chronic fatigue syndrome

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992020787A1 (en) * 1991-05-23 1992-11-26 William John Martin Stealth virus detection in the chronic fatigue syndrome

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992015325A1 (en) * 1991-02-28 1992-09-17 The United States Of America, Represented By The Secretary, United States Department Of Commerce Solomon islands variants of human t-lymphotropic virus
US5426028A (en) * 1991-07-05 1995-06-20 Rush-Presbyterian-St. Lukes Medical Center Screening method for chronic immune dysfunction syndrome

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992020787A1 (en) * 1991-05-23 1992-11-26 William John Martin Stealth virus detection in the chronic fatigue syndrome

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA. vol. 82, May 1985, WASHINGTON US pages 3101 - 3105 K. SHIMOTOHNO ET AL. *
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA. vol. 88, no. 7, 1 April 1991, WASHINGTON US pages 2922 - 2926 E. DEFREITAS ET AL. *
SCIENCE vol. 249, 14 September 1990, LANCASTER, PA US pages 1240 - 1241 J. PALCA *
See also references of WO9205760A1 *

Also Published As

Publication number Publication date
IE913042A1 (en) 1992-03-11
JPH06500928A (en) 1994-01-27
EP0546126A1 (en) 1993-06-16
AU657516B2 (en) 1995-03-16
PT98812A (en) 1992-09-30
AU1266292A (en) 1992-04-28
CA2089761A1 (en) 1992-03-01
WO1992005760A1 (en) 1992-04-16

Similar Documents

Publication Publication Date Title
EP0717592A4 (en) Method and composition for the treatment of apathy-amotivation syndrome
GB2246497B (en) Method and apparatus for adaptive phong shading
HRP950499B1 (en) Compositions and methods for treating mast-cell inflammatory condition
GB2278260B (en) Method and apparatus for cancelling spread-spectrum noise
EP0479367A3 (en) Method and apparatus for attenuating engine generated noise
DE3480406D1 (en) Method and siloxane composition for treating fibers
GB9608317D0 (en) A composition for preventing and treating kinetotia syndrome
GB2232724B (en) Noise reduction method
AU2338492A (en) Screening method for chronic fatigue syndrome
EP0372560A3 (en) Phosphors and method for treating the surface thereof
EP0546126A4 (en) Method and compositions for diagnosing and treating chronic fatigue immunodysfunction syndrome
EP0492680A3 (en) Method and apparatus for attenuating noise
EP0720049A3 (en) Photographic processing composition and processing method using the same
EP0492335A3 (en) Method for surface treatment
EP0741909A4 (en) Methods for improving semiconductor processing
HK1021316A1 (en) Use of mycobacterium vaccae for treating chronic fatigue syndrome
GB9102879D0 (en) Method,apparatus and composition
AU6060694A (en) Method for treating acquired immune deficiency syndrome
GB2248965B (en) Semiconductor testing method
RU1785711C (en) Method for reducing fatigue
ZA89282B (en) Agent for treating bradycardia and bradyarrhythmia
IL113444A0 (en) Compositions and methods for treating leukemia
EP0627623A3 (en) Method and apparatus for determining the surface structure of yarns.
ZA909765B (en) Vitamin-mineral treatment methods and compositions
GB9301720D0 (en) Method and compositions for treating anoestrus

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19930318

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19930602

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

17Q First examination report despatched

Effective date: 19961009

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19970221